home / stock / tyra / tyra news


TYRA News and Press, Tyra Biosciences Inc. From 11/02/22

Stock Information

Company Name: Tyra Biosciences Inc.
Stock Symbol: TYRA
Market: OTC
Website: tyra.bio

Menu

TYRA TYRA Quote TYRA Short TYRA News TYRA Articles TYRA Message Board
Get TYRA Alerts

News, Short Squeeze, Breakout and More Instantly...

TYRA - Tyra Biosciences Announces Planned Chief Financial Officer Transition

Tyra Biosciences Announces Planned Chief Financial Officer Transition PR Newswire - Esther van den Boom to transition to an advisor at year-end 2022- - Alan Fuhrman to be named Chief Financial Officer- CARLSBAD, Calif. , Nov. 2, 2022 ...

TYRA - Tyra Biosciences to Present Preclinical Data on TYRA-200, an FGFR1/2/3 Inhibitor, at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Tyra Biosciences to Present Preclinical Data on TYRA-200, an FGFR1/2/3 Inhibitor, at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics PR Newswire CARLSBAD, Calif. , Oct. 13, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TY...

TYRA - Tyra Biosciences to Participate at September 2022 Investor Conferences

Tyra Biosciences to Participate at September 2022 Investor Conferences PR Newswire CARLSBAD, Calif. , Sept. 8, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overco...

TYRA - Tyra Biosciences to Present Preclinical Data on TYRA-300, an FGFR3-selective Inhibitor, at ESMO 2022 Congress

Tyra Biosciences to Present Preclinical Data on TYRA-300, an FGFR3-selective Inhibitor, at ESMO 2022 Congress PR Newswire CARLSBAD, Calif. , Sept. 5, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on devel...

TYRA - Tyra Biosciences GAAP EPS of -$0.36

Tyra Biosciences press release ( NASDAQ: TYRA ): Q2 GAAP EPS of -$0.36. As of June 30, 2022, TYRA had cash and cash equivalents of $275.1 million. For further details see: Tyra Biosciences GAAP EPS of -$0.36

TYRA - Tyra Biosciences Reports Second Quarter 2022 Financial Results and Highlights

Tyra Biosciences Reports Second Quarter 2022 Financial Results and Highlights PR Newswire -IND clearance received from FDA to proceed with SURF301 Study of TYRA-300- -Pipeline on track; IND for TYRA-200 to be filed in 2H 2022- -Well-capitalized with cas...

TYRA - XORTX Therapeutics leads healthcare gainers, Humanigen and Atara Biotherapeutics among losers

Gainers: XORTX Therapeutics ( XRTX ) +39% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuticals ( RYTM ) +23% . Apollo Endosurgery ( APEN ) +18% . Tyra Biosciences ( TYRA ) +15% . Losers: Humanigen ( HGEN ) -80% . Atara Biotherap...

TYRA - CLVS, OMER and ALNA among mid-day movers

Gainers: Allena Pharmaceuticals ( ALNA ) +46% . Mega Matrix ( MTMT ) +43% . Faraday Future Intelligent Electric ( FFIE ) +30% . Tyra Biosciences ( TYRA ) +29% . Omeros ( OMER ) +28% . Clovis Oncology ( CLVS ) +22% . ...

TYRA - Accolade, Clovis Oncology top healthcare gainers; Talaris Therapeutics leads losers

Gainers: Accolade ( ACCD ) +18% . Clovis Oncology ( CLVS ) +18% . Larimar Therapeutics ( LRMR ) +14% . Tyra Biosciences ( TYRA ) +13% . VectivBio Holding ( VECT ) +13% . Losers: Talaris Therapeutics ( TALS ) -48% . Agile Therapeu...

TYRA - NeuroSense, Rapid Micro top healthcare gainers; Renalytix, Angion lead losers' pack

Gainers: NeuroSense Therapeutics ( NRSN ) +53% . Rapid Micro Biosystems ( RPID ) +36% . Burning Rock Biotech ( BNR ) +15% . Tyra Biosciences ( TYRA ) +7% . Addex Therapeutics ( ADXN ) +5% . Losers: Renalytix ( RNLX ) -40% ...

Previous 10 Next 10